companydata.dkFUJIFILM Diosynth Biotechnologies Denmark ApS
CVR: 26060702
Previous names: BIOGEN (DENMARK) MANUFACTURING ApS, BIOGEN IDEC (DENMARK) MANUFACTURING ApS, BIOGEN (DENMARK) MANUFACTURING ApS
The financial health of FUJIFILM Diosynth Biotechnologies Denmark ApS appears robust, with a significant increase in revenue from 2.73 billion DKK in 2021 to 4.80 billion DKK in 2025. Profitability has shown some volatility, peaking at 470 million DKK in 2023 before declining to 165 million DKK in 2025, indicating potential challenges in maintaining margins. The company's equity has steadily increased, reaching 5.11 billion DKK in 2025, which strengthens its financial position. As a player in the pharmaceutical manufacturing industry, its growth trajectory suggests a solid standing, although the declining profit trend may warrant closer scrutiny.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er at drive produktions- og handelsvirksomhed og at besidde kapitalandele i andre virksomheder samt at drive anden virksomhed, der efter direktionens skøn er forbunden hermed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 4.8 mia. | 165.1 mio. | 26.7 mia. | 5.1 mia. | 1761 | |
History
Ownership
Properties
(3)3 properties
Upgrade to Pro to see addresses, building data and ownership details
Management
Directors
Board
Founders
Production units (3)
Similar companies
Companies in the same industry and area